1. Home
  2. CTNM vs CZFS Comparison

CTNM vs CZFS Comparison

Compare CTNM & CZFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTNM
  • CZFS
  • Stock Information
  • Founded
  • CTNM 2009
  • CZFS 1984
  • Country
  • CTNM United States
  • CZFS United States
  • Employees
  • CTNM N/A
  • CZFS N/A
  • Industry
  • CTNM
  • CZFS Major Banks
  • Sector
  • CTNM
  • CZFS Finance
  • Exchange
  • CTNM Nasdaq
  • CZFS Nasdaq
  • Market Cap
  • CTNM 377.6M
  • CZFS 314.9M
  • IPO Year
  • CTNM 2024
  • CZFS N/A
  • Fundamental
  • Price
  • CTNM $11.28
  • CZFS $62.55
  • Analyst Decision
  • CTNM Strong Buy
  • CZFS Strong Buy
  • Analyst Count
  • CTNM 4
  • CZFS 1
  • Target Price
  • CTNM $29.25
  • CZFS N/A
  • AVG Volume (30 Days)
  • CTNM 135.4K
  • CZFS 15.6K
  • Earning Date
  • CTNM 02-16-2025
  • CZFS 01-28-2025
  • Dividend Yield
  • CTNM N/A
  • CZFS 3.18%
  • EPS Growth
  • CTNM N/A
  • CZFS 34.84
  • EPS
  • CTNM N/A
  • CZFS 5.75
  • Revenue
  • CTNM N/A
  • CZFS $98,201,000.00
  • Revenue This Year
  • CTNM N/A
  • CZFS N/A
  • Revenue Next Year
  • CTNM N/A
  • CZFS $9.21
  • P/E Ratio
  • CTNM N/A
  • CZFS $10.70
  • Revenue Growth
  • CTNM N/A
  • CZFS 19.13
  • 52 Week Low
  • CTNM $11.38
  • CZFS $38.52
  • 52 Week High
  • CTNM $22.00
  • CZFS $75.40
  • Technical
  • Relative Strength Index (RSI)
  • CTNM N/A
  • CZFS 48.60
  • Support Level
  • CTNM N/A
  • CZFS $59.50
  • Resistance Level
  • CTNM N/A
  • CZFS $62.98
  • Average True Range (ATR)
  • CTNM 0.00
  • CZFS 2.76
  • MACD
  • CTNM 0.00
  • CZFS 0.26
  • Stochastic Oscillator
  • CTNM 0.00
  • CZFS 65.45

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

About CZFS Citizens Financial Services Inc.

Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management and retirement services.

Share on Social Networks: